Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The bioavailability of the oral disintegrating tablet formulations given without water will
be similar to an equivalent dose of the standard oral tablet given with water.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.